Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TriGels F is a prescription-strength nutritional supplement developed by Trigen Laboratory, primarily indicated for the treatment of iron deficiency anemia and the prevention of folate deficiency, particularly in prenatal and postnatal care. The formulation is delivered as a softgel and contains a combination of carbonyl iron (75 mg), folic acid (1 mg), vitamin B12 (cyanocobalamin, 12 mcg), vitamin C (ascorbic acid, 50 mg), vitamin B6 (pyridoxine, 25 mg), and docusate sodium (50 mg). Carbonyl iron is utilized for its high elemental iron content and favorable safety profile compared to iron salts, while vitamin C is included to facilitate gastrointestinal iron absorption. The addition of docusate sodium serves as a stool softener to counteract the constipating effects typically associated with high-dose iron supplementation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TriGels F.